Insmed Incorporated $INSM
Clinical trial pipeline · active industry-sponsored Phase 1/2 to Phase 3 trials · updated 2026-11-19
ACTIVE TRIALS5
PHASE 3 / 2-35
RECRUITING4
READOUTS ≤12 MONTHS1
| TRIAL | PHASE | STATUS | CONDITION | N | PRIMARY COMPLETION |
|---|---|---|---|---|---|
| Treprostinil Palmitil NCT05649748 |
P2/3 | Active, not recruiting | Pulmonary Arterial Hypertension | 91 | 2026-12-31 |
| PALM-PAH NCT07481981 |
P3 | Recruiting | Pulmonary Arterial Hypertension | 344 | 2028-12-28 |
| PALM-ILD NCT07179380 |
P3 | Recruiting | Pulmonary Hypertension; Interstitial Lung Disease | 344 | 2028-12-30 |
| PALM-PPF NCT07805785 |
P3 | Recruiting | Progressive Pulmonary Fibrosis; Interstitial Lung Disease | 800 | 2030-08-31 |
| Treprostinil Palmitil Inhalation Powder NCT07234032 |
P3 | Recruiting | Pulmonary Hypertension; Interstitial Lung Disease | 344 | 2031-01-22 |